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Meta-analysis is not always 
the best way to round out 
a systematic review: a few 
thoughts prompted by the 
COVID-19 pandemic and 
“spiced-up” with an earthquake
The last few days of March 2020 in Zagreb, Croatia, were 
anything but usual early spring days. By the end of Febru-
ary, first patients with COVID-19 infection were identified, 
and hospitals were preparing for the (expected) increased 
number of patients, while most of them were consider-
ably damaged by two strong earthquakes that hit Zagreb 
on March 22. Just about the end of March, a paper was 
published (1) that drew our attention – we considered 
that it might be useful to forward it to our hospital col-
leagues who did not have time to search for the literature 
that might guide their practice. A collaboration of several 
research groups resulted in a prompt, thorough, and up-
to-date (at the time) systematic review focused on ob-
servational studies reporting on clinical, epidemiological, 
laboratory, and radiological characteristics and disease se-
verity and course in COVID-19 patients (1). A thorough risk 
of bias assessment was performed using a tool adapted 
for this kind of studies. A total of 60 studies were finally 
included – 20 case reports, 37 case series, and 3 epidemio-
logical reports involving between 1 and close to 50 000 pa-
tients per study, mostly from China, but also from 10 other 
countries (1). A number of meta-analytical estimates were 
generated in order to assess the prevalence of individual 
symptoms/signs, laboratory test values, and mortality – 
however, all were so severely heterogeneous that were 
completely non-informative. On the other hand, simply 
summarized data (as simple raw proportions), such as 
the percentage of patients with a certain laboratory 
value within or outside the physiological range, and narra-
tive parts on certain findings were more informative (1).
Meta-analysis, as a research method, was broadly accepted 
in health care already in the 1980s (2), just a few years after 
its initial outline (3). There is no need to provide specific 
references for the following several statements, as they are 
self-evident: a) since then, an enormous number of me-
ta-analytical methods have been developed (frequentist, 
Bayesian, direct, indirect, mixed-treatment, dose-response, 
for sparse data, meta-regression, etc); b) a number of user-
friendly software packages have been developed; c) annu-
al number of published meta-analyses pertaining to medi-
cine is huge. The potential value of a systematic review (as a 
method of comprehensive identification and re-evaluation 
of primary research) and usually adjacent meta-analysis (as 
a method of data aggregation across different studies) in 
health care is undoubted and has been long recognized 
(4,). However, meta-analysis, as any other research method, 
is continuously evolving; initial “technical flaws” are being 
recognized and corrected, while new (potential) issues are 
continuously being recognized and solved. In other words, 
in order to do a proper meta-analysis, methodological ex-
pertise is required (although this may not seem so when 
one starts any of the “user friendly” software packages). 
More than 25 years ago one of the great contributors to 
the concept and methodology of meta-analysis noted as 
follows (2): “There is currently a move to generate user-friendly 
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meta-analysis software packages. I have mixed feelings about 
this development. On one hand, software is essential… On the 
other hand, the ability to carry out multiple analyses routinely 
(note regression models for the case in point) often leads to 
poor data analysis. This, of course, should not be deterrent to 
creating good software. However, I would suggest a ‘Surgeon 
General’s warning’ on every software package: a meta-analysis 
is not to be undertaken lightly; it is not a simple procedure, nor 
is it a cure-all. It is time-consuming, requires specialists knowl-
edgeable about the treatment working with statisticians, and 
is subject to abuse: treat it with respect”. He in a way implied 
that meta-analysis could be methodologically (computa-
tionally) inadequate. Indeed, one (as an example of many) 
analysis (by expert methodologists) addressed several tens 
of thousands of meta-analyses in health care to conclude 
that around 20% of them were “flawed beyond repair” (5). 
However, the point that we would like to make is not strict-
ly methodological one, rather a conceptual one – when 
should one actually do a meta-analysis, ie, after completing 
a systematic review how to decide whether data should be 
pooled or not? This does not refer to the issue of repeat-
ing research that has already been done [in the mentioned 
analysis (5) some 27% of published meta-analyses were 
judged as “redundant and unnecessary”] but to the issue of 
usefulness. Probably the most important purpose of a me-
ta-analysis is to provide estimates that can improve the de-
cision-making process, ie, to help define certain milestones 
that are relevant for practice (6). If this is not possible, if 
such an informative estimate cannot be generated – what 
is the use of a pooled estimate? [In the cited analysis (5) 
some 17% of meta-analytical estimates were considered 
“decent (presumably – technically), but not useful”]. Would 
it not be of more use to provide some other form of data 
synthesis? There are a number of situations in which this 
dilemma arises, and several are exemplified here. Assume a 
situation in which all primary studies are heavily flawed by 
high risks of various biases. What would be the purpose of 
a meta-analytical effect pooling? Aggregating “bias” simply 
cannot result in estimates that are likely to be close to the 
truth (7). Similarly, pooling estimates across highly biased 
and good quality trials is not really a reasonable option. 
Hence, data from individual unbiased studies are far more 
likely to be practically useful. Another common situation 
is one in which there are only a few primary studies. Since 
the fixed-effect estimates (underlying assumption: a single 
parameter is common to all primary studies) are rarely jus-
tified in biomedical sciences (8), a small number of studies 
represents a technical, computational problem – random-
effects estimates would be needed and with just a few 
studies, estimation of the across-study variance (τ2) is high-
ly imprecise, and this affects the overall estimate. Under 
such conditions, it may be more informative (and closer to 
the “truth”) to simply present individual study results (9), al-
though there are methodological solutions that, however, 
require some expertise (10). This notion is directly linked to 
the typical situation of clinically (medically) heterogeneous 
primary studies (eg, different patient characteristics, study/
treatment duration, outcome measurement instruments, 
and other differences in study features). They (regardless 
of “statistical heterogeneity or homogeneity”) conceptu-
ally require the use of random-effects estimation (8,10) (re-
gardless of the number of studies). The assumption of one 
single population effect under so different circumstances 
is not realistic (8,10). Yet, while random-effects estimates do 
take into account between-study heterogeneity, they do 
not resolve it (8,10) – it comes to the proper understanding 
of such an estimate: the pooled random-effects estimate is 
an estimate of the mean of a range of population effects. 
When the number of primary studies is large, it is assumed 
that these effects are normally distributed, while when the 
number of studies is low, t-distribution is a more appropri-
ate assumption (8,10). This fact further implies that some of 
these effects might not differ from 0 (or 1.0 for ratio effect 
measures) [ie, there is a range of true effects, some might 
be far from 0 (or 1), some could embrace it, some could 
go into the opposite direction]. Hence, unless the meta-
analysis identifies settings (studies, subject characteristics, 
study characteristics, dosing, treatment duration, exact di-
agnosis, etc) in which there is an effect and those in which 
there is no effect, or settings with effects of different sizes 
– apart from the indication that, for example, some treat-
ment “on average” produces an effect – the overall esti-
mate may not be very informative for the practice since it 
does not “tell” under which circumstances the “treatment 
works,” and under which it “does not” or may be harmful. In 
such situations, the authors of meta-analysis should inform 
the readers about the dispersion of the estimated effects – 
by reporting the range of effects and prediction intervals 
– thus communicating the uncertainty (11,12).
To conclude, systematic reviews of the literature on a (bio)
medical topic are important and potentially highly useful 
tools. The same goes for meta-analytical effect estimates. 
However, there are situations in which meta-analytical es-
timates are not really needed (ie, as a “final step” rounding 
out a systematic review) as they – due to the nature of the 
primary studies – may not be informative and relevant for 
the practice or, moreover, could be misleading. There are 
situations in which different ways of data synthesis (eg, 
narratives) or even data from individual studies (pre-
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viously “filtered” on methodological grounds through the 
process of the systematic review) are much more informa-
tive and practically useful.
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